Related Experiment Video
Updated: Feb 5, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Nonmonotonic Dose-Response Curves Occur in Dose Ranges That Are Relevant to Regulatory Decision-Making.
Corinne E Hill1, J P Myers2, Laura N Vandenberg1
1Department of Environmental Health Sciences, School of Public Health and Health Sciences, Amherst, MA, USA.
Non-monotonic dose response curves (NMDRCs) are common and occur at low exposure levels for many chemicals. These findings challenge traditional toxicity testing, suggesting current safety assessments may be inadequate for protecting public health.
Area of Science:
- Toxicology
- Environmental Health
- Endocrinology
Background:
- Non-monotonic dose response curves (NMDRCs) are observed across biological systems in response to various chemical exposures.
- Regulatory agencies have historically underestimated the prevalence and relevance of NMDRCs, particularly for adverse outcomes and endocrine disrupting chemicals (EDCs).
- The linear dose-response model assumes high-dose hazards predict low-dose safety, a principle challenged by NMDRCs occurring below established safe levels.
Purpose of the Study:
- To provide evidence of NMDRCs occurring at low doses, below the no-observed-adverse-effect level (NOAEL).
- To discuss the implications of NMDRCs for regulatory decision-making and risk assessment.
- To advocate for the incorporation of NMDRC data into toxicity testing and reference dose calculations for improved public health protection.
Main Methods:
- Review and presentation of existing scientific literature and data on NMDRCs.
- Analysis of case studies involving specific chemicals like resveratrol, permethrin, chlorothalonil, phthalates (DEHP), and BPA.
- Discussion of regulatory assumptions and their limitations in light of NMDRC evidence.
Main Results:
- NMDRCs are demonstrated to occur below the NOAEL and even below reference doses for several chemicals.
- The CLARITY-BPA study indicated mammary tumors predominantly in rats exposed to the lowest BPA dose, supporting NMDRC findings.
- Evidence suggests NMDRCs are more common than previously acknowledged by regulatory bodies.
Conclusions:
- NMDRCs challenge the fundamental assumptions of traditional high-dose toxicity testing and extrapolation to low-dose safety.
- Regulatory frameworks need to acknowledge and integrate NMDRC data to ensure accurate risk assessment and public health protection.
- Revised methodologies for toxicity testing and reference dose calculation are necessary to account for NMDRCs effectively.
Related Concept Videos
Dose-Response Relationship: Overview
Dose-Response Relationship: Potency and Efficacy
Dose-Response Relationship: Selectivity and Specificity
Dose Size and Dosing Frequency: Determination Methods
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...

